KOVANAZE FDA approval date
The FDA approved KOVANAZE on 29 Jun 2016.
- FDA approval date
- 29 Jun 2016
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as OXYMETAZOLINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2016-06-29Day | KOVANAZE | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA208032", "applicant_as_listed_by_fda": "ST RENATUS", "brand_names": ["KOVANAZE"], "active_ingredients": ["OXYMETAZOLINE HYDROCHLORIDE", "TETRACAINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160629", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |